Gilead Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	9,216	8,510	480	5,613	4,566	6,201
Depreciation & Amortization	2,753	2,760	2,767	2,693	2,103	2,050
Stock-Based Compensation	903	894	835	766	637	635
Other Adjustments	969	1,803	7,626	1,236	3,529	2,009
Change in Receivables	-312	-367	139	157	-406	313
Changes in Inventories	-865	-1,036	-426	-842	-310	11
Changes in Accounts Payable	-94	-132	290	-347	226	-118
Changes in Accrued Expenses	-452	6	108	458	-775	689
Changes in Income Taxes Payable	-1,585	-2,108	-732	-1,768	-364	-361
Changes in Other Operating Activities	-318	-311	-259	39	-134	-45
Operating Cash Flow	10,215	10,019	10,828	8,006	9,072	11,384
Operating Cash Flow Growth	18.55%	-7.47%	35.25%	-11.75%	-20.31%	36.40%
Capital Expenditures	-576	-563	-523	-585	-728	-579
Purchases of Investments	-4,600	-4,072	-736	-2,372	-1,942	-3,897
Proceeds from Sale of Investments	3,465	909	2,592	1,844	2,002	2,910
Payments for Business Acquisitions	-906	-1,070	-4,840	-1,152	-1,797	-1,584
Other Investing Activities	8	2	58	-1	-1	19
Investing Cash Flow	-2,608	-4,793	-3,449	-2,265	-2,466	-3,131
Long-Term Debt Issued	-	-	3,464	1,980	-	-
Long-Term Debt Repaid	-2,792	-1,788	-1,970	-2,250	-1,500	-4,750
Net Long-Term Debt Issued (Repaid)	-2,792	-1,788	1,494	-270	-1,500	-4,750
Issuance of Common Stock	322	408	422	232	309	169
Repurchase of Common Stock	-1,611	-1,922	-1,150	-1,000	-1,396	-546
Net Common Stock Issued (Repurchased)	-1,289	-1,514	-728	-768	-1,087	-377
Common Dividends Paid	-4,033	-4,003	-3,918	-3,809	-3,709	-3,605
Other Financing Activities	-443	-440	-281	-279	-173	-145
Financing Cash Flow	-8,558	-7,745	-3,433	-5,125	-6,469	-8,877
Effect of Exchange Rate Changes on Cash and Cash Equivalents	62	92	-40	57	-63	-35
Net Cash Flow	-298	-2,428	3,906	673	74	-659
Free Cash Flow	9,639	9,456	10,305	7,421	8,344	10,805
Free Cash Flow Growth	1.93%	-8.24%	38.86%	-11.06%	-22.78%	40.40%
FCF Margin	32.42%	32.12%	35.84%	27.37%	30.59%	39.57%
Free Cash Flow Per Share	7.69	7.53	8.21	5.90	6.61	8.56
Levered Free Cash Flow	3,266	5,338	3,199	5,043	3,110	3,122
Unlevered Free Cash Flow	7,773	7,322	2,379	5,870	5,775	14,054

SEC Filings: 10-K · 10-Q